Multiple Sclerosis, Rituximab, Hypogammaglobu...

Dr. Jeff Ratliff talks with Dr. Gabriela Figueiredo Pucci about how participation in a social media community influenced PIF and career development among neurology trainees. Read the related article in Neurology® Education. Disclosures can be found at Neurology.org. 

Dr. Stacey Clardy talks with Dr. John Ney about wait times for new neurology office visits among commercially insured persons in the United States. Read the related article in Neurology®. Disclosures can be found at Neurology.org. 

Dr. Shuvro Roy and Dr. Annette Langer-Gould discuss the effective dose of rituximab and other B-cell depleting therapies in patients with multiple sclerosis, as well as important comorbidities to prevent infection risks. Show reference: https://www.neurology.org/doi/10.1212/NXI.0 ...  Show more

Systemic lupus erythematosus (SLE) can present at any age and is associated with immune-mediated damage to multiple organs and increased rates of cardiovascular disease, cancer, and disability. New treatments have been FDA approved. Caroline H. Siegel, MD, MS, discusses this a ...

This program discusses peripheral nerve diseases, including the anatomy of the central and peripheral nervous systems by Dr. Maggie Waung. Peripheral nerves control sensory, motor and autonomic functions and can regenerate though very slowly. Dr. Michael Wilson discusses difficul ...  Show more

Join experts Drs Matt Sparks and Dawn Caster as they discuss the complexities around the management of lupus nephritis. What tools do we have now? What is on the horizon? Tune in to find out. Relevant disclosures can be found with the episode show notes on Medscape ( https://www.m ...  Show more